The Executive Committee of Eckert & Ziegler Strahlen- und Medizintechnik AG EUZ today determined not to increase, or to continue to pursue, its offer to acquire Theragenics Corporation TGX due to continued resistance from the Theragenics board of directors against any kind of negotiated transaction, and for lack of evidence that the additional effort of a hostile take-over would be justified by the risk-adjusted business value of the target. Eckert & Ziegler therefore withdraws its offer to acquire Theragenics
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in